NASDAQ:CGIX - Cancer Genetics, Inc.
$0.16
 $-0.01
-3.10%
11:45AM EDT
2019-07-22
Cancer Genetics, Inc. is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide genomic and biomarker information. Its Select One Clinical Trials program provides a range of integrated and dynamic clinical trial services for both oncology and non-oncology genetic testing for Phase I-III trials along with ancillary services, including bioinformatics, biorepository and trials logistic support. The Company is developing a global footprint with locations in the United States, India and China. It also offers a portfolio of genotyping services, with access to over 400 validated genotyping assays, including Phase I and Phase II drug metabolizing enzymes, transporters, and receptors, and over 30 validated gene expression assays. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CGIX     avg for
industry  
  avg for
sector  
42 stocks weight:  -1000. 00 M 217. 37   399. 45  
42 stocks rank:  4. 54 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  
mean recommendation:  3. 00   2. 10   2. 04  

quick ratio:  0. 28   5. 49   1. 88  
current ratio:  0. 36   5. 87   2. 36  

target price low:  0. 30   83. 44   114. 90  
target price avg:  0. 30   106. 20   137. 90  
target price high:  0. 30   132. 30   158. 97  
1-yr high:  1. 26   111. 86   142. 57  
last close:  0. 17   86. 79   125. 44  
50-day avg:  0. 18   86. 68   122. 63  
200-day avg:  0. 33   89. 22   121. 38  
1-yr low:  0. 16   69. 78   100. 51  
volume:  2. 13 M 2. 62 M 3. 43 M
50-day avg volume:  1. 50 M 3. 20 M 4. 16 M
200-day avg volume:  1. 51 M 2. 99 M 4. 75 M

1-day return:  -6. 94 % -1. 30 % -0. 99 %
this week return:  -4. 29 % 0. 45 % -0. 20 %
12-wk return:  -23. 86 % 0. 94 % 4. 84 %
52-wk return:  -80. 94 % -1. 30 % 10. 55 %

enterprise value (EV):  24. 92 M 45. 10 B 122. 38 B
market cap:  9. 68 M 38. 96 B 108. 40 B
EBITDA:  -14. 01 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 78   5. 38   11. 93  
enterprise/revenue (EV/R):  0. 94   57. 92   10. 21  
total revenue:  26. 64 M 9. 91 B 39. 98 B
total debt:  15. 94 M 10. 90 B 17. 48 B
debt/equity:  207. 51   57. 18   120. 05  
net income (common):  -20. 53 M 2. 07 B 4. 05 B

shares outstanding:  27. 75 M 538. 09 M 1. 24 B
shares:  47. 27 M 548. 00 M 1. 22 B
shares short:  2. 79 M 10. 98 M 11. 87 M
shares short prior month:  2. 70 M 9. 32 M 12. 05 M
short ratio:  4. 03   5. 60   3. 34  
short % of float:  5. 73 % 6. 48 % 2. 64 %
total cash/share:  0. 01   10. 98   9. 19  
total cash:  697. 00 K 5. 93 B 6. 10 B
free cash flow:  333. 75 K 2. 92 B 4. 55 B
operating cash flow:  -12. 54 M 3. 80 B 5. 78 B

book value:  0. 14   13. 35   27. 45  
price/book:  1. 23   4. 60   8. 78  
gross profits:  8. 75 M 7. 44 B 36. 13 B
operating margins:  -59. 74 % -308. 40 % -28. 55 %
EBITDA margins:  -52. 59 % 13. 17 % 23. 38 %
profit margins:  -77. 07 % 10. 44 % 14. 18 %
gross margins:  31. 39 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 63   2. 10   4. 23  
forward EPS:  -0. 06   3. 45   7. 10  
P/E:  -0. 27   1. 90   32. 10  
forward P/E:  -2. 79   6. 46   15. 47  
PE/G:  0. 02   0. 70   -0. 54  
growth:  -10. 80 % 265. 63 % 79. 11 %
earnings high:  -0. 00   0. 89   1. 68  
earnings avg:  -0. 00   0. 70   1. 57  
earnings low:  -0. 00   0. 46   1. 46  
revenue high:  10. 77 M 2. 57 B 11. 07 B
revenue avg:  10. 77 M 2. 51 B 10. 91 B
revenue low:  10. 77 M 2. 45 B 10. 73 B
return on assets:  -23. 42 % -2. 34 % 5. 28 %
return on equity:  -148. 08 % -90. 08 % 133. 53 %
revenue growth:  -10. 80 % 265. 25 % 73. 68 %
revenue/share:  0. 81   12. 72   60. 04  

beta (1yr vs S&P500):  1. 15   1. 27   0. 91  
sharpe (1yr):  -0. 40   0. 16   0. 77  

held % insiders:  24. 60 % 6. 06 % 3. 29 %
held % institutions:  13. 41 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CGIX
.    100.566 =       100.566 :: --> INITIAL WEIGHT <--
.     - 0.63 =        99.936 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.945 =       194.418 :: P/E factor
.    x 2.209 =       429.461 :: PE/G factor
.    x 1.627 =       698.783 :: beta factor
.    x 0.783 =       547.117 :: sharpe factor
.    x 2.062 =      1128.265 :: current ratio factor
.    x 1.477 =      1665.921 :: quick ratio factor
.    x 1.117 =      1861.169 :: short ratio factor
.    x 1.016 =      1891.212 :: EV/R factor
.    x 1.006 =      1902.822 :: price-to-book factor
.    x 1.672 =      3181.361 :: debt-to-revenue factor
.    x 1.621 =      5158.324 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     10939.737 :: sector+industry 1-year gains factor
.    x 1.009 =     11042.878 :: industry 12-weeks return factor
.    x 1.308 =     14442.854 :: industry 2-weeks return factor
.    x 1.079 =     15590.409 :: 5-day avg > 50-day avg
.    x 0.948 =     14772.669 :: "drift" penalty 2 days ago
.    x 0.953 =     14077.252 :: "drift" penalty 3 days ago
.    x 0.969 =     13642.198 :: "drift" penalty 4 days ago
.     x 0.96 =     13094.844 :: "drift" penalty 5 days ago
.    / 2.223 =       5889.95 :: overall "drift" factor
.    x 0.798 =      4700.128 :: largest single-day jump factor
.    x 0.059 =       276.275 :: low price factor
.    x 0.192 =        53.053 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.004 =         0.191 :: forward EPS factor
.    x 0.638 =         0.122 :: forward P/E factor
.    x 1.185 =         0.144 :: industry recommendation factor
.    x 1.688 =         0.244 :: company recommendation factor
.    x 1.003 =         0.244 :: factor historical industry gain for week 29
.    x 10.77 =         2.632 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         1.274 :: reduced for readability
.    + 1.363 =         2.637 :: add/subtract for investor sentiment
. -999999999.999 zero/no returns for 10 days out of the past 42x trading days
.                               --> FINAL WEIGHT <--
.                  -999999999.999 :: FINAL WEIGHT for NASDAQ:CGIX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org